Top Abortion Researcher Gets Funding Cut by Trump Admin Over Nonsensical ‘Gender Identity’ Claim
Diana Greene Foster—who received a MacArthur Genius Grant following her landmark Turnaway Study—has been researching post-Roe abortion access.
Photo: YouTube AbortionLatestPolitics
Trump’s Health and Human Services Department has been taking a hatchet to vitally important, lifesaving programs and research, especially involving reproductive health, claiming that researchers, health providers, and federal employees are promoting “DEI.” On Wednesday, the 19th reported another alarming casualty: Diana Greene Foster, the researcher behind the landmark Turnaway Study, lost a grant from the National Institutes of Health to study the impacts of state abortion bans on patients.
Over 10 years, the Turnaway Study, for which Foster received a MacArthur Genius Grant, followed thousands of people who both had abortions or were unable to access abortion, and found that those who were denied care were substantially more likely to live in poverty or be entrapped in abusive relationships, among other devastating circumstances. Foster’s been in thee process of following up this research in the wake of Dobbs v. Jackson Women’s Health—the Supreme Court case that overturned Roe v. Wade–when she received a letter from the NIH informing her that “research programs based on gender identity are often unscientific, have little identifiable return on investment, and do nothing to enhance the health of many Americans.” This is similar to letters other researchers have received, including one who was told her program to address gaps in research on the impacts of domestic violence on high rates of maternal mortality no longer qualifies for funding because of its “amorphous equity objectives.” The Pregnancy Risk Assessment Monitoring System (PRAMS), which studies the massive race and class disparities in maternal mortality, also lost funding for a similar reason.
Foster told the 19th that her team has thus far used less than $200,000 from an anticipated $2.5 million in NIH support to be spread over five years. While she intends to continue the study, she’ll now be forced to use valuable time fundraising to keep it alive: “I am madly fundraising to replace these canceled funds,” she said. “I would rather be spending the time implementing the study than beginning the fundraising again.”